Deal Radar 2009: Hippo

You’ve often heard me use the expression Built To Enjoy. Today’s Deal Radar showcases a quintessential Built To Enjoy company. Hippo is an open source information centered Content Management System (CMS) which targets medium to large enterprises to manage their content for multi-channel distribution like websites and intranets.  The company has been around for ten years and has a deep commitment to open source.  >>>

Healthcare Supply Chain Management: Medassets CEO John Bardis (Part 6)

SM: What is your revenue model like for your services group? Do you charge on a flat fee basis or do you have a success based fee model?

JB: It depends on what the client would like. We often take on risk in very large transactions. We call those transformationals. >>>

Sales Strategy Roundtable Tomorrow With InsideView

Please register here for a Sales Strategy Roundtable tomorrow morning.

Deal Radar 2009: HealthEdge

As the call for radical changes to the US healthcare system grows louder, tech companies continue to offer new solutions, such as value-based plans, and software that improves basic administrative tasks such as claims processing. Our latest company in the category, HealthEdge, provides an enterprise-class software suite that allows healthcare payors to take on new business, streamline their current business and give real-time responses to market changes and new regulations. Their main product, HealthRules, includes next-generation claims and benefit administration, business intelligence and portal solutions. >>>

Healthcare Supply Chain Management: Medassets CEO John Bardis (Part 5)

SM: Let’s talk about your actual business model. How do you get paid with your system?

JB: Once we learned that medical supply utilization was a critical element of determining reimbursement for hospitals, we embarked on a process of building the nation’s most comprehensive set of tools to manage revenue cycle for US hospitals and healthcare providers. >>>

Catching Up On Readings: Trust Through Transparency

Here is a summary of the posts from this past week, in case you missed them. >>>

The Truth About Licensing A Product (Part 2)

By Guest Author Jim DeBetta of the Academy for Entrepreneurs

[Jim’s four-part series tells entrepreneurs and investors what they need to know about licensing a product through a discussion of the terms that drive the license’s value. In today’s post, Jim shows entrepreneurs how they can negotiate the best royalty rate possible.]

2. Royalty—Sometimes Lower is Higher

One of the most important aspects of a license is the royalty rate.  This is the percentage that the licensee agrees to pay you for the rights to the patent and product.  Inventors naturally want to negotiate the highest possible royalty.  But a high royalty isn’t always to the inventor’s benefit. >>>

Building Your Brand Experience for Hard Times (Part 3)

By guest authors Charles W. Bush and Kathy Hwang of 3Strand, a brand and business strategy consultancy.

Build trust with customers through transparency.

Just after the financial crisis, research conducted by OTO Research shows that 83% of consumers do not trust the brands they use. Everyone is talking about building brand trust during a recession, so how exactly are companies doing it? >>>